Johnson & Johnson (JNJ) news
Recent news
J&J's Duato discloses $1.69M share sale at avg. $258.74
Johnson & Johnson (JNJ) CEO Joaquin Duato recently sold 6,530 shares of company stock at an average price of $258.74 per share, totaling approximately $1.69 million. This transaction is part of a broader pattern of insider selling activity, with executives collectively selling shares worth over…
AInvest Wire · Aug 8, 2026Genmab - net sales of Darzalex by J&J $8.17 bln for first six months of 2026, up 21%
AInvest Wire · Aug 6, 2026Johnson & Johnson's EVP Jennifer Taubert to retire; Tom Cavanaugh named EVP, Worldwide Chairman Innovative Medicine
AInvest Wire · Aug 4, 2026Johnson & Johnson shares fall 1.8% after $2.58B Sail Bio deal
AInvest Wire · Jul 29, 2026JNJ to make payments of $785M, incl. $465M equity investment
Johnson & Johnson (JNJ) has announced a series of financial commitments totaling $785 million, including a $465 million equity investment, as part of a strategic initiative. The move reflects the company’s ongoing efforts to strengthen its portfolio through targeted investments and partnerships.…
AInvest Wire · Jul 29, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.